ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1387 • 2014 ACR/ARHP Annual Meeting

    Radiographic Progression Differs Between Trajectory Clusters Defined By DAS28 Scores in Early Rheumatoid Arthritis

    Cheryl Barnabe1, Ye Sun2, Gilles Boire3, Carol Hitchon4, Edward C. Keystone5, J. Carter Thorne6, Boulos Haraoui7, Jeffrey R. Curtis8, Désirée van der Heijde9, Diane Tin10, Janet E. Pope11 and Vivian P. Bykerk12, 1Division of Rheumatology, University of Calgary, Calgary, AB, Canada, 2Mount Sinai Hospital, Toronto, ON, Canada, 3Rheumatology Division, CHUS - Sherbrooke University, Sherbrooke, QC, Canada, 4Rheumatology, University of Manitoba, Winnipeg, MB, Canada, 5Medicine, University of Toronto, Toronto, ON, Canada, 6Southlake Regional Health Centre, Newmarket, Newmarket, ON, Canada, 7Department of Medicine, Centre Hospitalier de l’Université de Montréal, Montréal, QC, Canada, 8The University of Alabama at Birmingham, Birmingham, AL, 9Rheumatology, Leiden University Medical Ctr, Leiden, Netherlands, 10The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, 11Medicine, Western University, London, ON, Canada, 12Rheumatology, Hospital for Special Surgery, New York, NY

    Background/Purpose: Group-based trajectory modeling defines clusters of individuals in observed data with similar disease trajectories. We have previously defined five distinct trajectories in early rheumatoid…
  • Abstract Number: 1386 • 2014 ACR/ARHP Annual Meeting

    Disease Flares during 10 Year Follow-up in Patients with Rheumatoid Arthritis Are Associated with Joint Damage Progression and Disability

    I.M. Markusse1, L. Dirven2, Y.P. Goekoop-Ruiterman3, P.a. van der Lubbe4, A.J. Peeters5, P.J.S.M. Kerstens6, W.F. Lems7,8, T.W.J. Huizinga2 and C.F. Allaart2, 1Leiden University Medical Center, Leiden, Netherlands, 2Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Rheumatology, HAGA hospital, The Hague, Netherlands, 4Rheumatology, Vlietland Hospital, Schiedam, Netherlands, 5Rheumatology, Reinier de Graaf Gasthuis, Delft, Netherlands, 6Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands, 7Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands, 8Rheumatology, VU Medical Center, Amsterdam, Netherlands

    Background/Purpose: Disease flares frequently occur in patients with rheumatoid arthritis (RA). It has been suggested that these may spontaneously remit, in which case targeted treatment…
  • Abstract Number: 1385 • 2014 ACR/ARHP Annual Meeting

    What Discriminates Best Flares in Rheumatoid Arthritis (RA)? a Subanalysis of the Strass Treatment Tapering in RA Study

    Agnès Danré1, Bruno Fautrel2, Toni Alfaiate3, Thao Pham4, Jacques Morel5, Emmanuelle Dernis Labous6, Philippe Gaudin7, Olivier Brocq8, Elisabeth Solau-Gervais9, Jean-Marie Berthelot10, Jean Charles Balblanc11, Xavier Mariette12, Florence Tubach13 and Laure Gossec14, 1Rheumatology, La Pitié Salpêtrière, Paris, France, 2Rheumatology, Pitie Salpetriere Hospital, Paris, France, 3department of epidemiology, biostatistics and clinical research, APHP, Hospital Bichat, Paris, France, 4Rheumatology, Sainte Marguerite Hospital, Marseille, France, 5Department of Rheumatology, Hôpital Lapeyronie, Montpellier, France, 6Rhumatologie, Ch Du Mans, Le Mans, France, 7Rhumatologie, Hopital Sud Grenoble, Echirolles, France, 8Rheumatology, Hospital of Princesse Grâce de Monaco, Monaco, France, 9Rheumatology, University Hospital of Poitiers, Poitiers, France, 10Rheumatology, CHU Nantes (Nantes University Hospital), Nantes, France, 11Rhumatologie, Ch de Belfort, Belfort Cedex, France, 12Rheumatology, University Hospital, Le Kremlin Bicetre, Paris, France, 13INSERM, Universite Paris Diderot, Paris, France, 14Rheumatology, UPMC GRC08, Paris 06 University, Pitié Salpétrière Hospital, Paris, France

    Background/Purpose Flares in rheumatoid arthritis (RA) are a patient-perceived increase of disease activity which might be particularly important to assess in the context of treatment…
  • Abstract Number: 1384 • 2014 ACR/ARHP Annual Meeting

    Fibromyalgia and Its Effect on Treatment Response in Early Rheumatoid Arthritis Patients  

    Josefina Durán Santa Cruz1, Bernard Combe2, Jingbo Niu1, Nathalie Rincheval3, Cécile Gaujoux-Viala4 and David T. Felson5, 1Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 2Immuno-Rhumatologie, Hôpital Lapeyronie, Montpellier, France, 3Institut Universitaire de Recherche Clinique, Montpellier, France, 4EA 2415, Montpellier I University, Nîmes University Hospital, Rheumatology Department, Nîmes, France, 5Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA

    Background/Purpose: Fibromyalgia (FM) occurs commonly in patients with rheumatoid arthritis (RA) and its effect on treatment response is unknown. In this study we aimed to…
  • Abstract Number: 1382 • 2014 ACR/ARHP Annual Meeting

    The Longitudinal Course of Fatigue in Rheumatoid Arthritis – Results from the Norfolk Arthritis Register

    Katie L Druce1, Gareth T Jones2, Gary J. Macfarlane1, Suzanne M. Verstappen3 and Neil Basu1, 1Musculoskeletal Research Collaboration (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom, 2Musculoskeletal Research Collaboration (Epidemiology Group),, University of Aberdeen, Aberdeen, United Kingdom, 3Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, United Kingdom

    Background/Purpose: Fatigue is common and burdensome in Rheumatoid Arthritis (RA). Though RA fatigue progression varies significantly between individuals, to date, published analyses have only considered…
  • Abstract Number: 1401 • 2014 ACR/ARHP Annual Meeting

    Higher-Order Neuropsychological Deficits Are Frequent and Occur Early in RA and SLE: The Impact of Basic Processing Abilities on Psychological Well-Being

    Giorgia Dimitraki1, Georgia Ktistaki1, Emmanouil Papastefanakis1, Antonis Fanouriakis2, Irini Gergiannaki2, George Bertsias3, Nikolaos Kougkas2, Argyro Repa3, Evangelos Karademas1, Prodromos Sidiropoulos3 and Panagiotis Simos1, 1Department of Psychology, University of Crete, Rethymnon, Greece, 2Rheumatology, Clinical Immunology and Allergy, University of Crete, Heraklion, Greece, 3Rheumatology, Clinical Immunology, and Allergy, University of Crete, Heraklion, Greece

    Background/Purpose Deficits in higher-order cognitive abilities (episodic memory, executive functions) have been reported in patients with chronic inflammatory disorders, albeit inconsistently. We investigated whether such…
  • Abstract Number: 1400 • 2014 ACR/ARHP Annual Meeting

    Risk of Venous Thromboembolic Events in Patients with Rheumatoid Arthritis: A Meta-Analysis of Observational Studies

    Michelle Avina1, Sally Choi2, Sharan Rai3, Hyon K. Choi4 and Mary De Vera3,5, 1Faculty of Sciences, Arthritis Research Centre of Canada/University of British Columbia, Richmond, BC, Canada, 2Arthritis Research Centre of Canada/University of British Columbia, Richmond, BC, Canada, 3Arthritis Research Centre of Canada, Richmond, BC, Canada, 4Boston University School of Medicine, Boston, MA, 5Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: Venous thromboembolism (VTE), which includes both deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third most common vascular event after myocardial infarction…
  • Abstract Number: 1399 • 2014 ACR/ARHP Annual Meeting

    Proteinase K-like Serine Protease PCSK9 Influence on the Dyslipidemia and Endothelial Dysfunction Observed in Rheumatoid Arthritis Patients

    Esmeralda Delgado-Frias1, Ivan Ferraz-Amaro2, Vanesa Hernandez-Hernandez3, A.M. de Vera-Gonzalez4, A.F. Gonzalez-Rivero5, Miguel A. González-Gay6 and Federico Diaz-Gonzalez7, 1Rheumatology, Servicio de Reumatología.Hospital Universitario de Canarias, La Laguna. Tenerife., Spain, 2Rheumatology, Servicio de Reumatologia. Hospital Universitario de Canarias, Tenerife, Spain, 3Rheumatology, Servicio de Reumatologia.Hospital Universitario de Canarias., La Laguna. Tenerife, Spain, 4Laboratorio Central, Servicio de Laboratorio Central.Hospital Universitario de Canarias., La Laguna. Spain, Spain, 5Laboratorio Central, Servicio de Laboratorio Central. Hospital Universitario de Canarias., La Laguna. Tenerife., Spain, 6Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, 7Rheumatology, Servicio de Reumatologia.Hospital Universitario de Canarias, La Laguna, Spain

    Background/Purpose Proteinase K-like serine protease PCSK9 binds the low-density lipoprotein (LDL) receptor at the surface of hepatocytes, thereby preventing its recycling and enhancing its degradation…
  • Abstract Number: 1383 • 2014 ACR/ARHP Annual Meeting

    Disease Characteristics and RA Development in Undifferentiated Arthritis: A 2-Year Follow-up Study of 413 Patients with Arthritis of Less Than 16 Weeks Duration

    Gina Hetland Brinkmann1,2, Ellen Sauar Norli1,3, Tore K. Kvien1, Anne Julsrud Haugen2, Lars Grøvle2, Halvor Nygaard4, Cathrine Thunem5, Maria Dahl Mjaavatten1 and Elisabeth Lie1, 1Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Dept. of Rheumatology, Østfold Hospital Trust, Fredrikstad, Norway, 3Dept. of Rheumatology, Martina Hansens Hospital, Bærum, Norway, 4Dept. of Rheumatology, Lillehammer Hospital of Rheumatic Diseases, Lillehammer, Norway, 5Dept. of Medicine, Telemark Hospital, Skien, Norway

    Background/Purpose: Correct identification of the subset of patients with undifferentiated arthritis (UA) who will develop rheumatoid arthritis (RA) is important to enable initiation of appropriate…
  • Abstract Number: 1380 • 2014 ACR/ARHP Annual Meeting

    Patient Global Impression of Change for Patient Reported Outcomes in Rheumatoid Arthritis: Impact of Comorbidities

    Pankaj Bansal1, Aneet Kaur2, Horace Spencer2 and Nasim A. Khan3, 1Rheumatology/ Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, 2University of Arkansas for Medical Sciences, Little Rock, AR, 3Rheumatology, University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System, Little Rock, AR

    Background/Purpose: Understanding patient’s perspective of minimally clinically important difference (MCID) in health (or disease) status is important to improve patient-centered clinical care and planning and…
  • Abstract Number: 1379 • 2014 ACR/ARHP Annual Meeting

    Studies on Ageing and the Severity of Radiographic Joint Damage in Rheumatoid Arthritis

    L. Mangnus1, H.W. van Steenbergen1, E. Brouwer2, E. Lindqvist3, M. Reijnierse4, P.K. Gregersen5, S. M. Rantapää-Dahlqvist6, D. M. van der Heijde1 and A. H. M. van der Helm- van Mil1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Dept. of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 3Rheumatology, Lund University, Lund, Sweden, 4Radiology, Leiden University Medical Center, Leiden, Netherlands, 5The Feinstein Institute for Medical Research, Manhasset, NY, 6Department for Public Health and Clinical Medicine/ Rheumatology, Umeå University, Umeå, Sweden

    Background/Purpose: The Western population is getting older; consequently the proportion of elderly persons presenting with Rheumatoid Arthritis (RA) is increasing. We studied whether age is…
  • Abstract Number: 1378 • 2014 ACR/ARHP Annual Meeting

    the Impact of Rheumatoid Arthritis Activity and Medications on Pregnancy Outcomes

    Megan E. B. Clowse, Rheumatology, Duke University Medical Center, Durham, NC

    Background/Purpose:   While rheumatoid arthritis (RA) has historically improved in pregnancy, recent studies suggest the improvement may not be dramatic now that we are able…
  • Abstract Number: 1377 • 2014 ACR/ARHP Annual Meeting

    Anti-Citrullinated Peptide Antibody Titers and the Prevalence of Interstitial Lung Disease in Patients with and without Rheumatoid Arthritis

    Chase Correia1, Melissa R. Bussey2, Brittany Panico1, Rong Guo3 and Rochella A. Ostrowski4, 1Internal Medicine, Loyola University Medical Center, Chicago, IL, 2Rheumatology, Division of Rheumatology, Loyola University Medical Center, Maywood, IL, 3Loyola University Medical Center, Chicago, IL, 4Rheumatology, Loyola University Medical Center, Maywood, IL

    Background/Purpose:   Rheumatoid arthritis (RA) is a multisystem inflammatory disease characterized by a symmetric, destructive polyarthritis.  Interstitial lung disease (ILD) is an extra-articular manifestation that…
  • Abstract Number: 1376 • 2014 ACR/ARHP Annual Meeting

    Angiographic Pattern Among Rheumatoid Arthritis Patients Who Are Hospitalized Due to Acute Coronary Syndrome

    Marie Holmqvist1, Ängla Mantel2, Tomas Jernberg3, Stefan James4, Solveig Wållberg-Jonsson5 and Johan Askling6, 1Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden, 2Dept of Medicine, Clinical Epidemiology Unit, Dept of Medicine, Karolinska Institutet, Solna, Sweden, 3Department of medicine, Section of Cardiology, Karolinska University Hospital, Stockholm, Sweden, 43Department of Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden, 5Rheumatology, Institution of Public health and clinical medicine/ Rheumatology, University of Umeå, Umeå, Sweden, 6Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: We aimed at investigating and to compare the angiographic pattern of stenoses in patients with rheumatoid arthritis (RA) and general population comparators hospitalized due…
  • Abstract Number: 1375 • 2014 ACR/ARHP Annual Meeting

    Educational Level and Not Ethnicity an Important Determinant of Disease Progression in Patients with Rheumatoid Arthritis

    Sharon Dowell1, Gail S. Kerr2, Yusuf Yazici3, Christopher Swearingen4, Mercedes Quinones5, Luis R. Espinoza6, Edward L. Treadwell7, Theresa Lawrence-Ford8, Yvonne Sherrer9, Angelia Mosley-WIlliams10, Ignacio Garcia-Valladares11, Rodolfo Perez Alamino12, Chunqiao Luo13, Akgun Ince14, Adrian Godoy1 and John Amatruda15, 1Division of Rheumatology, Howard University, Washington, DC, 2Rheumatology, Washington DC VAMC, Georgetown and Howard University, Washington, DC, 3Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 4Pediatrics and Biostatistics, University of Arkansas, Little Rock, AR, 5Division of Rheumatology, Howard University Hospital, Washington, DC, 6Medicine-Section of Rheum, LSU Medical Center, New Orleans, LA, 7Dept Medicine Div of Rheum, East Carolina University, Greenville, NC, 8North Georgia Rheumatology Group, PC, Lawrenceville, GA, 9Rheum/Immunology, Centre Rheum Immunol Arthritis, Fort Lauderdale, FL, 10Rheumatology, Detroit VAMC, Detroit, MI, 11Immunology and Rheumatology, Hospital General de Occidente, Zapopan, Jal., Mexico, 12internal Medicine, LSUHSC, New Orleans, LA, 13University of Arkansas for Medical Sciences, Little Rock, AR, 14Arthitis Consultants Inc, St. Louis University, St. Louis, MO, 15Rheumatology, Howard University, Washington, DC

    Background/Purpose: Formal educational level is often used as a surrogate for socioeconomic status and in patients with rheumatoid arthritis (RA), low levels have been associated…
  • « Previous Page
  • 1
  • …
  • 2139
  • 2140
  • 2141
  • 2142
  • 2143
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology